Literature DB >> 24726472

Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems.

Anneke T Vulto-van Silfhout1, Shivakumar Rajamanickam2, Philip J Jensik2, Sarah Vergult3, Nina de Rocker3, Kathryn J Newhall4, Ramya Raghavan2, Sara N Reardon2, Kelsey Jarrett2, Tara McIntyre2, Joseph Bulinski2, Stacy L Ownby2, Jodi I Huggenvik2, G Stanley McKnight4, Gregory M Rose5, Xiang Cai2, Andy Willaert3, Christiane Zweier6, Sabine Endele6, Joep de Ligt1, Bregje W M van Bon1, Dorien Lugtenberg1, Petra F de Vries1, Joris A Veltman1, Hans van Bokhoven7, Han G Brunner1, Anita Rauch8, Arjan P M de Brouwer7, Gemma L Carvill9, Alexander Hoischen1, Heather C Mefford9, Evan E Eichler10, Lisenka E L M Vissers1, Björn Menten3, Michael W Collard2, Bert B A de Vries11.   

Abstract

Recently, we identified in two individuals with intellectual disability (ID) different de novo mutations in DEAF1, which encodes a transcription factor with an important role in embryonic development. To ascertain whether these mutations in DEAF1 are causative for the ID phenotype, we performed targeted resequencing of DEAF1 in an additional cohort of over 2,300 individuals with unexplained ID and identified two additional individuals with de novo mutations in this gene. All four individuals had severe ID with severely affected speech development, and three showed severe behavioral problems. DEAF1 is highly expressed in the CNS, especially during early embryonic development. All four mutations were missense mutations affecting the SAND domain of DEAF1. Altered DEAF1 harboring any of the four amino acid changes showed impaired transcriptional regulation of the DEAF1 promoter. Moreover, behavioral studies in mice with a conditional knockout of Deaf1 in the brain showed memory deficits and increased anxiety-like behavior. Our results demonstrate that mutations in DEAF1 cause ID and behavioral problems, most likely as a result of impaired transcriptional regulation by DEAF1.
Copyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24726472      PMCID: PMC4067565          DOI: 10.1016/j.ajhg.2014.03.013

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

Review 1.  De novo mutations in human genetic disease.

Authors:  Joris A Veltman; Han G Brunner
Journal:  Nat Rev Genet       Date:  2012-07-18       Impact factor: 53.242

2.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.

Authors:  Anita Rauch; Dagmar Wieczorek; Elisabeth Graf; Thomas Wieland; Sabine Endele; Thomas Schwarzmayr; Beate Albrecht; Deborah Bartholdi; Jasmin Beygo; Nataliya Di Donato; Andreas Dufke; Kirsten Cremer; Maja Hempel; Denise Horn; Juliane Hoyer; Pascal Joset; Albrecht Röpke; Ute Moog; Angelika Riess; Christian T Thiel; Andreas Tzschach; Antje Wiesener; Eva Wohlleber; Christiane Zweier; Arif B Ekici; Alexander M Zink; Andreas Rump; Christa Meisinger; Harald Grallert; Heinrich Sticht; Annette Schenck; Hartmut Engels; Gudrun Rappold; Evelin Schröck; Peter Wieacker; Olaf Riess; Thomas Meitinger; André Reis; Tim M Strom
Journal:  Lancet       Date:  2012-09-27       Impact factor: 79.321

3.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism.

Authors:  Stephan J Sanders; Michael T Murtha; Abha R Gupta; John D Murdoch; Melanie J Raubeson; A Jeremy Willsey; A Gulhan Ercan-Sencicek; Nicholas M DiLullo; Neelroop N Parikshak; Jason L Stein; Michael F Walker; Gordon T Ober; Nicole A Teran; Youeun Song; Paul El-Fishawy; Ryan C Murtha; Murim Choi; John D Overton; Robert D Bjornson; Nicholas J Carriero; Kyle A Meyer; Kaya Bilguvar; Shrikant M Mane; Nenad Sestan; Richard P Lifton; Murat Günel; Kathryn Roeder; Daniel H Geschwind; Bernie Devlin; Matthew W State
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

4.  Diagnostic exome sequencing in persons with severe intellectual disability.

Authors:  Joep de Ligt; Marjolein H Willemsen; Bregje W M van Bon; Tjitske Kleefstra; Helger G Yntema; Thessa Kroes; Anneke T Vulto-van Silfhout; David A Koolen; Petra de Vries; Christian Gilissen; Marisol del Rosario; Alexander Hoischen; Hans Scheffer; Bert B A de Vries; Han G Brunner; Joris A Veltman; Lisenka E L M Vissers
Journal:  N Engl J Med       Date:  2012-10-03       Impact factor: 91.245

5.  Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3.

Authors:  Linda Yip; Remi J Creusot; Cara T Pager; Peter Sarnow; C Garrison Fathman
Journal:  J Mol Cell Biol       Date:  2012-08-24       Impact factor: 6.216

6.  Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.

Authors:  Brian J O'Roak; Laura Vives; Wenqing Fu; Jarrett D Egertson; Ian B Stanaway; Ian G Phelps; Gemma Carvill; Akash Kumar; Choli Lee; Katy Ankenman; Jeff Munson; Joseph B Hiatt; Emily H Turner; Roie Levy; Diana R O'Day; Niklas Krumm; Bradley P Coe; Beth K Martin; Elhanan Borenstein; Deborah A Nickerson; Heather C Mefford; Dan Doherty; Joshua M Akey; Raphael Bernier; Evan E Eichler; Jay Shendure
Journal:  Science       Date:  2012-11-15       Impact factor: 47.728

7.  Contribution of DEAF1 structural domains to the interaction with the breast cancer oncogene LMO4.

Authors:  Liza Cubeddu; Soumya Joseph; Derek J Richard; Jacqueline M Matthews
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

8.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.

Authors:  Brian J O'Roak; Laura Vives; Santhosh Girirajan; Emre Karakoc; Niklas Krumm; Bradley P Coe; Roie Levy; Arthur Ko; Choli Lee; Joshua D Smith; Emily H Turner; Ian B Stanaway; Benjamin Vernot; Maika Malig; Carl Baker; Beau Reilly; Joshua M Akey; Elhanan Borenstein; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Jay Shendure; Evan E Eichler
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

9.  Structural and functional analysis of the DEAF-1 and BS69 MYND domains.

Authors:  Fatiha Kateb; Helene Perrin; Konstantinos Tripsianes; Peijian Zou; Roberta Spadaccini; Matthew Bottomley; Titus M Franzmann; Johannes Buchner; Stephane Ansieau; Michael Sattler
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

10.  DEAF1 is a Pellino1-interacting protein required for interferon production by Sendai virus and double-stranded RNA.

Authors:  Alban Ordureau; Karine Enesa; Sambit Nanda; Brice Le Francois; Mark Peggie; Alan Prescott; Paul R Albert; Philip Cohen
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

View more
  32 in total

1.  Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.

Authors:  Jinchen Li; Tao Cai; Yi Jiang; Huiqian Chen; Xin He; Chao Chen; Xianfeng Li; Qianzhi Shao; Xia Ran; Zhongshan Li; Kun Xia; Chunyu Liu; Zhong Sheng Sun; Jinyu Wu
Journal:  Mol Psychiatry       Date:  2015-04-07       Impact factor: 15.992

Review 2.  Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops.

Authors:  Caitlin Mullins; Gord Fishell; Richard W Tsien
Journal:  Neuron       Date:  2016-03-16       Impact factor: 17.173

Review 3.  Next-Generation Sequencing in Intellectual Disability.

Authors:  Gemma L Carvill; Heather C Mefford
Journal:  J Pediatr Genet       Date:  2015-10-12

4.  A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency.

Authors:  Sandra Jansen; Alexander Hoischen; Bradley P Coe; Gemma L Carvill; Hilde Van Esch; Daniëlle G M Bosch; Ulla A Andersen; Carl Baker; Marijke Bauters; Raphael A Bernier; Bregje W van Bon; Hedi L Claahsen-van der Grinten; Jozef Gecz; Christian Gilissen; Lucia Grillo; Anna Hackett; Tjitske Kleefstra; David Koolen; Malin Kvarnung; Martin J Larsen; Carlo Marcelis; Fiona McKenzie; Marie-Lorraine Monin; Caroline Nava; Janneke H Schuurs-Hoeijmakers; Rolph Pfundt; Marloes Steehouwer; Servi J C Stevens; Connie T Stumpel; Fleur Vansenne; Mirella Vinci; Maartje van de Vorst; Petra de Vries; Kali Witherspoon; Joris A Veltman; Han G Brunner; Heather C Mefford; Corrado Romano; Lisenka E L M Vissers; Evan E Eichler; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2017-12-05       Impact factor: 4.246

5.  Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variants.

Authors:  Seth I Berger; Carla Ciccone; Karen L Simon; May Christine Malicdan; Thierry Vilboux; Charles Billington; Roxanne Fischer; Wendy J Introne; Andrea Gropman; Jan K Blancato; James C Mullikin; William A Gahl; Marjan Huizing; Ann C M Smith
Journal:  Hum Genet       Date:  2017-02-17       Impact factor: 4.132

6.  Functional analysis of novel DEAF1 variants identified through clinical exome sequencing expands DEAF1-associated neurodevelopmental disorder (DAND) phenotype.

Authors:  Li Chen; Philip J Jensik; Joseph T Alaimo; Magdalena Walkiewicz; Seth Berger; Elizabeth Roeder; Eissa A Faqeih; Jonathan A Bernstein; Ann C M Smith; Sureni V Mullegama; David W Saffen; Sarah H Elsea
Journal:  Hum Mutat       Date:  2017-09-23       Impact factor: 4.878

7.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.

Authors:  F Kyle Satterstrom; Jack A Kosmicki; Jiebiao Wang; Michael S Breen; Silvia De Rubeis; Joon-Yong An; Minshi Peng; Ryan Collins; Jakob Grove; Lambertus Klei; Christine Stevens; Jennifer Reichert; Maureen S Mulhern; Mykyta Artomov; Sherif Gerges; Brooke Sheppard; Xinyi Xu; Aparna Bhaduri; Utku Norman; Harrison Brand; Grace Schwartz; Rachel Nguyen; Elizabeth E Guerrero; Caroline Dias; Catalina Betancur; Edwin H Cook; Louise Gallagher; Michael Gill; James S Sutcliffe; Audrey Thurm; Michael E Zwick; Anders D Børglum; Matthew W State; A Ercument Cicek; Michael E Talkowski; David J Cutler; Bernie Devlin; Stephan J Sanders; Kathryn Roeder; Mark J Daly; Joseph D Buxbaum
Journal:  Cell       Date:  2020-01-23       Impact factor: 41.582

8.  A Multiplex Human Pluripotent Stem Cell Platform Defines Molecular and Functional Subclasses of Autism-Related Genes.

Authors:  Gustav Y Cederquist; Jason Tchieu; Scott J Callahan; Kiran Ramnarine; Sean Ryan; Chao Zhang; Chelsea Rittenhouse; Nadja Zeltner; Sun Young Chung; Ting Zhou; Shuibing Chen; Doron Betel; Richard M White; Mark Tomishima; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2020-07-02       Impact factor: 24.633

9.  Diverse Non-genetic, Allele-Specific Expression Effects Shape Genetic Architecture at the Cellular Level in the Mammalian Brain.

Authors:  Wei-Chao Huang; Elliott Ferris; Tong Cheng; Cornelia Stacher Hörndli; Kelly Gleason; Carol Tamminga; Janice D Wagner; Kenneth M Boucher; Jan L Christian; Christopher Gregg
Journal:  Neuron       Date:  2017-02-23       Impact factor: 17.173

Review 10.  The Developmental Gene Hypothesis for Punctuated Equilibrium: Combined Roles of Developmental Regulatory Genes and Transposable Elements.

Authors:  Emily L Casanova; Miriam K Konkel
Journal:  Bioessays       Date:  2020-01-14       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.